{
  "docId": "019de076-39d2-7099-ad19-065ffc77ed59",
  "docSlug": "e110bee9f1b318f547399ddf66ee5ee3",
  "documentTitle": "Exscientia | Results Presentation Deck | 24 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 24,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses MIDD (Model-informed drug development) as a strategic framework for clinical progression.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-39d2-7099-ad19-065ffc77ed59/7",
  "deckHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59",
  "deckJsonHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59.json",
  "deckAnchorHref": "/decks/019de076-39d2-7099-ad19-065ffc77ed59#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.45,
        "y": 0.15
      },
      "kind": "list",
      "text": "IND submission in 1Q 2024. Expect to commence healthy volunteer study in US: Establish therapeutic dose; Enable combination therapy studies at outset. Following completion of healthy volunteer study: Commence simultaneous trials in AML and SCLC. Patient selection work ongoing with precision medicine platform",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3240f321-05b8-4f67-b745-e3b21ae09931",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.35,
        "x": 0.05,
        "y": 0.55
      },
      "kind": "list",
      "text": "Applying biological/statistical models from clinical and preclinical data to: Assess benefits/risks and inform decisions; Better define therapeutic index (TI) and maximise patient benefit. Healthy volunteer study to facilitate optimisation of TI",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e1f169eb-db27-491f-b26d-c484010c8004",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.35,
        "x": 0.05,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Model-informed drug development (MIDD)",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "407f2db4-3a91-4581-ab79-d83ebec41ee4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.25,
        "x": 0.05,
        "y": 0.1
      },
      "kind": "title",
      "text": "539 Moving into the clinic",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab84c9db-4cb7-4f07-9919-5295f9908ecb",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "roadmap",
      "slug": null,
      "matchId": "19d5a99f-4f88-4e60-b612-78150eba75d5",
      "evidence": "The slide outlines a sequence of future clinical development milestones.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 4,
      "beatId": "7d3d7752-d9ec-4ba0-921e-c4049dd71ceb",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "The document presents various evidence, including data and results, to support its claims and pipeline advancement",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 4,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "8341406f-e753-49e5-aaa2-5cfaa5dad183",
      "evidence": "The document presents a logical chain of events, from the platform to pipeline advancement",
      "position": 0,
      "objective": "How does Exscientia's AI-driven platform drive pipeline advancement",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}